Analyst at Wedbush Morgan comments on Savient (Nasdaq: SVNT) ahead of the PDUFA date for gout treatment KRYSTEXXA, which is ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE